Mayu Yoshikawa

MiRTeL Co. Ltd. engages in the business of gene testing services. Its services include research and development of health diagnostic systems; clinical examination and health related materials to medical care; sale of medical devices; clinical testing and clinical diagnostic services; planning of medical and information systems related to clinical testing; manufacturing, sale, import and export of pharmaceutical products and health foods; collection and delivery of reagents, containers and materials; manufacture and sale of DNA measuring kits; and all types of businesses related to clinical laboratories. The company was founded on September 3, 2012 and is headquartered in Hiroshima, Japan.